Vitamin D Status and Efficacy of Vitamin D Supplementation in Atopic Dermatitis: A Systematic Review and Meta-Analysis

Nutrients
Q1
Dec 2016
Citations:124
Influential Citations:4
Systematic Reviews / Meta-Analyses
62
S2 IconPDF Icon

Enhanced Details

Methods
Systematic review including observational studies (AD patients vs healthy controls; ~986 AD patients and 657 controls) and randomized, double-blind, placebo-controlled trials evaluating vitamin D supplementation in AD patients (pediatric and adult).
Results
Atopic dermatitis patients have lower serum 25(OH)D levels than healthy controls, especially in pediatric patients. In four randomized, double-blind trials, vitamin D supplementation reduced AD severity: SCORAD decreased by 5.85 points (95% CI −7.66 to −4.05) and EASI decreased by 3.14 points (95% CI −6.12 to −0.15). The pediatric subgroup showed a larger SCORAD reduction (−7.43; 95% CI −9.70 to −5.16; I2 = 0%). Vitamin D supplementation could be a new therapeutic option for reducing AD severity; further large, well-controlled trials are needed to confirm these findings and optimize baseline vitamin D status and dosing.
Limitations
Limitations include lack of baseline and post-supplementation 25(OH)D data; no adjustment for confounders (sun exposure, latitude, season, outdoor activity, diet); substantial interstudy heterogeneity; small number of randomized trials; limited adult data; need larger, subgroup-specific trials.

Abstract

Recent literature has highlighted the possible role of vitamin D in atopic dermatitis (AD), and that vitamin D supplementation might help to treat AD. This study determined the relationship between vitamin D level and AD, and assessed the efficacy of...